ADVERTISEMENT
Videos
Approaching MRD in Multiple Myeloma
05/07/2020
At the 2020 Great Debates and Updates in Hematologic Malignancies Meeting in Los Angeles, Thomas Martin, MD, the University of California, San Francisco, discussed the evolution of minimal residual disease testing in MM and whether or not it is ready for prime time.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement